Checking in on AdaptHealth Corp. (AHCO) after recent insiders movement


AdaptHealth Corp.’s recently made public that its 10% Owner Everest Hill Group Inc. unloaded Company’s shares for reported $0.13 million on Nov 02. In the deal valued at $23.00 per share,5,859 shares were sold. As a result of this transaction, Everest Hill Group Inc. now holds 14,023,581 shares worth roughly $ 309.78 million.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Then, Everest Hill Group Inc. sold 45,999 shares, generating $1,057,977 in total proceeds. Upon selling the shares at $23.00, the 10% Owner now owns 14,029,440 shares.

Before that, Everest Hill Group Inc. sold 10,437 shares. AdaptHealth Corp. shares valued at $240,051 were divested by the 10% Owner at a price of $23.00 per share. As a result of the transaction, Everest Hill Group Inc. now holds 14,075,439 shares, worth roughly $310.93 million.

SVB Leerink initiated its AdaptHealth Corp. [AHCO] rating to an Outperform in a research note published on Friday, September 27, 2021; the price target was $30. PT values the company’s stock at a premium of 26.37 to its Friday closing price. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who increased its forecast for the stock in mid July from “a Neutral” to “an Outperform”. Robert W. Baird also remained covering AHCO and has decreased its forecast on April 13, 2021 with a “Neutral” recommendation from previously “an Outperform” rating. Truist started covering the stock on March 18, 2021. It rated AHCO as “a Buy”.

Price Performance Review of AHCO

On Friday, AdaptHealth Corp. [NASDAQ:AHCO] saw its stock jump 3.51% to $22.09. On the same session, the stock had its day’s lowest price of $21.26, but rose to a high of $22.129. Over the last five days, the stock has lost -3.62%. AdaptHealth Corp. shares have fallen nearly -9.69% since the year began. Nevertheless, the stocks have fallen -14.55% over the past one year. While a 52-week high of $28.75 was reached on 08/03/22, a 52-week low of $11.40 was recorded on 05/09/22. SMA at 50 days reached $20.32, while 200 days put it at $18.44. A total of 1.54 million shares were traded, compared to the trading of 0.8 million shares in the previous session.

Levels Of Support And Resistance For AHCO Stock

The 24-hour chart illustrates a support level at 21.52, which if violated will result in even more drops to 20.96. On the upside, there is a resistance level at 22.39. A further resistance level may holdings at 22.70. The Relative Strength Index (RSI) on the 14-day chart is 54.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.72%. Stochastics %K at 50.34% indicates the stock is a holding.

How much short interest is there in AdaptHealth Corp.?

A steep rise in short interest was recorded in AdaptHealth Corp. stocks on Jul 14, 2022, growing by 50000.0 shares to a total of 5.83 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 5.78 million shares. There was a rise of 0.86%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 5.94% of the overall stock float, the days-to-cover ratio (short ratio) rose to 5.96.

AdaptHealth Corp. [AHCO] – Who Are The Largest Shareholders?

In filings from Deerfield Management Co. LP, it is revealed that the company now owns 11,150,797 shares, or roughly 8.29% of the outstanding AHCO shares. In other words, the investor’s shares have fallen by -499,275 from its previous 13-F filing of 11650072.0. Additionally, The Vanguard Group, Inc. decreased -6.24% of its stake after which the total value it holdings stand at $123,967,926, while Fidelity Management & Research Co added 19.78% of its stake to hold $108.22 million in the firm. Over the last quarter, BlackRock Fund Advisors purchased 31,423 shares of AdaptHealth Corp., while Rubric Capital Management LP bought 300,837 shares. At present, Silvercrest Asset Management Grou is holding 2,937,602 shares valued at $55.17 million. Nikko Asset Management Co., Ltd. owned 2,917,783 shares of the company at the time of its most recent 13F filing, worth $54.8 million.

According to FactSet, AdaptHealth Corp.’s share price will average $28.30 in the next year, based on opinions of analysts polled by the firm. This is up nearly 31.21 percent from its previous closing price of $21.34. Analysts expect AdaptHealth Corp. stock to reach the higher price of $35.00, while the lowest price estimate is $24.00. However, 10 analysts have rated AHCO stock as a Buy in their predictions for 2022. The most recent change occurred on January 26, 2021 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $46 price target.


Please enter your comment!
Please enter your name here